KEYTRUDA 25 mg/mL concentrate for solution for infusion, BAY 734506
TRIO041
Phase 3 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, BAY 734506 for Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria. is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active